LESLIE W REITMAN
Allopathic & Osteopathic Physicians|Internal Medicine|Geriatric Medicine AURORA, CO NPI 1013036714
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Geriatric Medicine CO Vanda Pharmaceuticals Inc. All categories
General Payments — all program years on this page
$1,258.69
- Category: General Payments
- Program years: PY2018–2020
- Record count: 74
- As of (CMS publication): 2026-01-23
Latest program year (PY2020): $151.41 across 8 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2020) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $151.41 | 8 |
By paying entity
Latest program year (PY2020) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Vanda Pharmaceuticals Inc. | $35.08 | 2 |
| Gilead Sciences, Inc. | $23.45 | 1 |
| Amgen Inc. | $22.76 | 1 |
| Astellas Pharma US Inc | $22.04 | 1 |
| Acerta Pharma LLC | $17.52 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $16.01 | 1 |
| Janssen Pharmaceuticals, Inc | $14.55 | 1 |
By program year
Records — PY2020 (8)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 718373423 | Astellas Pharma US Inc | $22.04 | 01/30/2020 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 719265633 | Janssen Pharmaceuticals, Inc | $14.55 | 09/03/2020 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 720697709 | Boehringer Ingelheim Pharmaceuticals, Inc. | $16.01 | 03/02/2020 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 735142351 | Vanda Pharmaceuticals Inc. | $18.89 | 01/06/2020 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 735142355 | Vanda Pharmaceuticals Inc. | $16.19 | 02/05/2020 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 736308943 | AstraZeneca Pharmaceuticals LP | $17.52 | 01/23/2020 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 741197511 | Amgen Inc. | $22.76 | 08/17/2020 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 748000027 | Gilead Sciences, Inc. | $23.45 | 02/18/2020 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2020_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.